U.S. Markets closed
  • A lot of talk about "opioid crisis" today on CNBC. Talk about lying of big drug makers about addictiveness of the opioids. About 5 minutes ago, 2:10 PM ....6/22/17.
  • what's going on with reph?
  • I think REPH might have reached its upward limit and that a pullback may be possible. the other week awesomeS-TOCKS alerted this company i think. google them .
  • Earnings were great good job REPH.
  • $REPH Announces Successful Top-Line Results from Phase 3 Safety Study of IV Meloxicam. On Track to File NDA in Q 3 (link: https://globenewswire.com/news-release/2017/05/09/980896/0/en/Recro-Pharma-Announces-Successful-Top-Line-Results-from-Phase-III-Safety-Study-of-IV-Meloxicam.html#.WRGiA-0E0Ug.twitter) globenewswire.com/news-release/2…
    7:04 AM · May 9, 2017

  • this stock is depressing
  • Why all the insider selling? Why aren't they holding?
  • Additional Buying Of REPH By Institution

    http://www.nasdaq.com/article/stonepine-capital-management-llc-buys-recro-pharma-sciclone-pharmaceuticals-novelion-cm764323

    Stonepine Capital Management, LLC Buys Recro Pharma, SciClone Pharmaceuticals, Novelion ...
    Stonepine Capital Management, LLCNew Purchases: SCLN , NVLN , OPHT , ENTA, VCYT, BDSI, SCMP, TRIB, MNK,Added Positions:REPH, CRME, ALIM, ALR, VCEL,.
    www.nasdaq.com
  • Received an alert this am about $REPH from http://yugestocks.com/?s=REPH, you may want to take a look. Investing trading stocks. The captain's postulate: we are all in the same boat - the titanic.

    Yuge Stocks: Trading Stocks and Making Money
    Stock alerts from the Yuge Stocks. Stock trading, making money and always looking for the next big money maker.
    yugestocks.com
  • http://monstastocks.com/?s=REPH has an alert for $REPH. Did anyone happen to see it as well? Looking for some good positive information from the company! A camel is a horse designed by a committee. Trading stocks investing.

    Monsta Stocks: Trading Stocks and Making Money
    Stock alerts from the Monsta Stocks. Stock trading, making money and always looking for the next big money maker.
    monstastocks.com
  • Recro Pharma Completes Enrollment in Phase III Safety Study of IV Meloxicam

    GlobeNewswire•February 27, 2017Comment
    MALVERN, Pa., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (REPH), a revenue generating specialty pharmaceutical company focused on products for hospital and other acute care settings, currently developing non-opioid products for the treatment of serious acute pain, today announced completion of enrollment for its double-blind Phase III safety study evaluating the safety and tolerability of intravenous (IV) meloxicam (N1539) following major surgery.

    In this multicenter, randomized, double-blind, placebo-controlled clinical trial, over 700 patients were enrolled and randomly assigned to receive a postoperative regimen of IV meloxicam (30mg bolus injection) or placebo in a 3:1 ratio, once every 24 hours for up to 7 doses following a variety of major elective surgical procedures, including total hip and knee replacements, hernia repair, and spinal, colorectal, and other major surgeries.

    “This is an important milestone in the clinical development of IV meloxicam, and marks the completion of enrollment in the third Phase III trial in Recro’s lead development program,” said Gerri Henwood, Recro Pharma’s President and Chief Executive Officer. “We continue to plan to file a New Drug Application (NDA) filing in the summer of 2017.”
  • This company will report a major progress and good earning/revenue growth! How come the stock price gets held down at this level???
  • Found a great no fee daytrading newsletter, vist T0pMarketGaIners.c0m and sign up...so glad I did
  • http://monstatrader.com/?s=REPH has an alert for $REPH. Did anyone happen to see it as well? Looking for some good positive information from the company! The light of a hundred stars does not equal the light of the moon. Day trading making money.

    MonstaTrader: OTC, NYSE, NASDAQ Stock Alerts for all Traders
    Stock alerts, stock trading, making money, sharing knowledge and always looking for the next big money maker.
    monstatrader.com
  • Sorry for typo.

    Hah, some people think this company is so cheap for $15 per share buy out?
  • Buy out is coming for $35 per share!
  • Buy out is coming for $15 per share!
  • If you believe that the company's, non-opioid pain drugs will be approved and sales will be above $500M, then you have to believe that the stock price will be north of $40 per share.
  • The markets will most likely collapse sometime this year…Are you prepared? Google LionStackAlerts, they only alert short term trades that work in any market…Do this now before it’s too late.